Severe and moderate haemophilia A and B in US females

Haemophilia

Volumn 20, Issue 2, 2014, Pages

  Di Michele, D M ^a,d   Gibb, C ^a   Lefkowitz, J M ^b   Ni, Q ^a,e   Gerber, L M ^a   Ganguly, A ^c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e ALLERGAN INC   (United States)

Author keywords

Females; Genotype; Haemophilia A; Haemophilia B; Moderate haemophilia; Severe haemophilia

Indexed keywords

FEMALES; GENOTYPE; HAEMOPHILIA A; HAEMOPHILIA B; MODERATE HAEMOPHILIA; SEVERE HAEMOPHILIA;

CYTOGENETIC ANALYSIS; FACTOR IX; FACTOR VIII; FEMALE; HEMOPHILIA A; HEMOPHILIA B; HUMANS; MALE; MUTATION; PHENOTYPE; QUALITY OF LIFE; REGISTRIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 84894106315     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/hae.12364     Document Type: Article

References (42)

1. Mannucci PM. Back to the future: a recent history of haemophilia treatment. Haemophilia 2008; 14(Suppl. 3): 10-8.
2. Byams VR, Kouides PA, Kulkarni R et al. Surveillance of female patients with inherited bleeding disorders in United States Haemophilia Treatment Centres. Haemophilia 2011; 17(Suppl. 1): 6-13.
3. David D, Morais S, Ventura C, Campos M. Female haemophiliac homozygous for the factor VIII intron 22 inversion mutation, with transcriptional inactivation of one of the factor VIII alleles. Haemophilia 2003; 9: 125-30.
4. Favier R, Lavergne JM, Costa JM et al. Unbalanced X-chromosome inactivation with a novel FVIII gene mutation resulting in severe hemophilia A in a female. Blood 2000; 96: 4373-5.
5. Okumura K, Fujimori Y, Takagi A et al. Skewed X chromosome inactivation in fraternal female twins results in moderately severe and mild haemophilia B. Haemophilia 2008; 14: 1088-93.
6. Krepischi-Santos AC, Carneiro JD, Svartman M, Bendit I, Odone-Filho V, Vianna-Morgante AM. Deletion of the factor IX gene as a result of translocation t(X;1) in a girl affected by haemophilia B. Br J Haematol 2001; 113: 616-20.
7. Renault NK, Dyack S, Dobson MJ, Costa T, Lam WL, Greer WL. Heritable skewed X-chromosome inactivation leads to haemophilia A expression in heterozygous females. Eur J Hum Genet 2007; 15: 628-37.
8. Cai XH, Wang XF, Dai J et al. Female hemophilia A heterozygous for a de novo frameshift and a novel missense mutation of factor VIII. J Thromb Haemost 2006; 4: 1969-74.
9. Lusher JM, McMillan CW. Severe factor VIII and factor IX deficiency in females. Am J Med 1978; 65: 637-48.
10. Yang MY, Ragni MV. Clinical manifestations and management of labor and delivery in women with factor IX deficiency. Haemophilia 2004; 10: 483-90.
11. Kadir RA, Economides DL, Sabin CA, Pollard D, Lee CA. Assessment of menstrual blood loss and gynaecological problems in patients with inherited bleeding disorders. Haemophilia 1999; 5: 40-8.
12. Bullinger M, von Mackensen S. Quality of life assessment in haemophilia. Haemophilia 2004; 10(Suppl. 1): 9-16.
13. Miners AH, Sabin CA, Tolley KH, Jenkinson C, Kind P, Lee CA. Assessing health-related quality-of-life in individuals with haemophilia. Haemophilia 1999; 5: 378-85.
14. Manco-Johnson M, Morrissey-Harding G, Edelman-Lewis B, Oster G, Larson P. Development and validation of a measure of disease-specific quality of life in young children with haemophilia. Haemophilia 2004; 10: 34-41.
15. Johansson EE, Hamberg K, Westman G, Lindgren G. The meanings of pain: an exploration of women's descriptions of symptoms. Soc Sci Med 1999; 48: 1791-802.
16. Citron M, Godmilow L, Ganguly T, Ganguly A. High throughput mutation screening of the factor VIII gene (F8C) in hemophilia A: 37 novel mutations and genotype-phenotype correlation. Hum Mutat 2002; 20: 267-74.
17. Mitchell M, Keeney S, Goodeve A. The molecular analysis of haemophilia B: a guideline from the UK haemophilia centre doctors' organization haemophilia genetics laboratory network. Haemophilia 2005; 11: 398-404.
18. Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet 1992; 51: 1229-39.
19. McHorney CA, Ware JE, Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993; 31: 247-63.
20. Quittner AL, Davis MA, Modi AC. Health-related quality of life in pediatric populations. In: Roberts MC ed. Handbook of Pediatric Psychology (3rd Edition). New York: Guilford Press, 2003: 696-709.
21. Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care 2001; 39: 800-12.
22. Plug I, Mauser-Bunschoten EP, Brocker-Vriends AH et al. Bleeding in carriers of hemophilia. Blood 2006; 108: 52-6.
23. Nisen P, Stamberg J, Ehrenpreis R et al. The molecular basis of severe hemophilia B in a girl. N Eng J Med 1986; 315: 1139-42.
24. Carcao MD, van den Berg HM, Ljung R, Mancuso ME. Correlation between phenotype and genotype in a large unselected cohort of children with severe hemophilia A. Blood 2013; 121: 3946-52.
25. Den Uijl I, Biesma D, Grobbee D, Fischer K. Outcome in moderate haemophilia. Blood Transfus 2012; 20: 1-7.
26. Greer IA, Lowe GD, Walker JJ, Forbes CD. Haemorrhagic problems in obstetrics and gynaecology in patients with congenital coagulopathies. Br J Obstet Gynaecol 1991; 98: 909-18.
27. Chi C, Lee CA, Shiltagh N, Khan A, Pollard D, Kadir RA. Pregnancy in carriers of haemophilia. Haemophilia 2008; 14: 56-64.
28. James AH. More than menorrhagia: a review of the obstetric and gynaecological manifestations of bleeding disorders. Haemophilia 2005; 11: 295-307.
29. Talaulikar D, Shadbolt B, McDonald A, Pidcock M. Health-related quality of life in chronic coagulation disorders. Haemophilia 2006; 12: 633-42.
30. Vuorma S, Teperi J, Hurskainen R, Aalto AM, Rissanen P, Kujansuu E. Correlates of women's preferences for treatment of heavy menstrual bleeding. Patient Educ Couns 2003; 49: 125-32.
31. Kadir RA, Sabin CA, Pollard D, Lee CA, Economides DL. Quality of life during menstruation in patients with inherited bleeding disorders. Haemophilia 1998; 4: 836-41.
32. Kouides PA. Females with von Willebrand disease: 72 years as the silent majority. Haemophilia 1998; 4: 665-76.
33. Eiser C, Morse R. Can parents rate their child's health-related quality of life? Results of a systematic review. Qual Life Res 2001; 10: 347-57.
34. Archer H, Evans J, Leonard H et al. Correlation between clinical severity in patients with Rett syndrome with a p. R168X or p.T158M MECP2 mutation, and the direction and degree of skewing of X-chromosome inactivation. J Med Genet 2007; 44: 148-52.
35. Lutskiy MI, Sasahara Y, Kenney DM, Rosen FS, Remold-O'Donnell E. Wiskott-Aldrich syndrome in a female. Blood 2002; 100: 2763-8.
36. Bennett CM, Boye E, Neufeld EJ. Female monozygotic twins discordant for hemophilia A due to nonrandom X-chromosome inactivation. Am J Hematol 2008; 83: 778-80.
37. Orstavik KH, Scheibel E, Ingerslev J, Schwartz M. Absence of correlation between X chromosome inactivation pattern and plasma concentration of factor VIII and factor IX in carriers of haemophilia A and B. Thromb Haemost 2000; 83: 433-7.
38. Tan SS, Williams EA, Tam PP. X-chromosome inactivation occurs at different times in different tissues of the post-implantation mouse embryo. Nat Genet 1993; 3: 170-4.
39. Gale RE, Wheadon H, Boulos P, Linch DC. Tissue specificity of X-chromosome inactivation patterns. Blood 1994; 83: 2899-905.
40. Carrel L, Hunt PA, Willard HF. Tissue and lineage-specific variation in inactive X chromosome expression of the murine Smcx gene. Hum Mol Genet 1996; 5: 1361-6.
41. Bittel DC, Theodoro MF, Kibiryeva N, Fischer W, Talebizadeh Z, Butler MG. Comparison of X-chromosome inactivation patterns in multiple tissues from human females. J Med Genet 2008; 45: 309-13.
42. Busque L, Mio R, Mattioli J et al. Nonrandom X-inactivation patterns in normal females: lyonization ratios vary with age. Blood 1996; 88: 59-65.